BioSpace News Archive

Equicare Health, the leading provider of oncology care coordination and patient navigation solutions, will introduce the latest release of their product, ECS 4.9, at the ASTRO 2018 Annual Meeting in San Antonio.

The U.S. Department of Agriculture (USDA), the U.S. Environmental Protection Agency (EPA), and the U.S. Food and Drug Administration (FDA) today announced the signing of a joint agency formal agreement under the Winning on Reducing Food Waste initiative.

Weight Watchers International, Inc. (NASDAQ: WTW) (“WW”) will release its results for the third quarter 2018 after market close on Thursday, November 1, 2018.

SHINE Medical Technologies Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, and Phoenix, LLC, manufacturer of the world’s strongest compact neutron generators, announced today that Phoenix has delivered the first production accelerator to SHINE’s Building One,

The Help Group Summit – Advances and Best Practices in Autism, Learning Disabilities and ADHD will take place on October 19 and 20 at the Skirball Cultural Center in Los Angeles.

The world’s experts in healthcare, technology, biopharma, and more will convene for the eighth annual Exponential Medicine conference (ExponentialMedicine.com), November 4-7 at the Hotel del Coronado in San Diego.

BioNano Genomics Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and ultra-specific structural variation detection in genome analysis, announces a series of presentations at the upcoming American Society of Human Genetics (ASHG) Annual Meeting, October 16 to 20 in San Diego, California.

Bionano Genomics, Inc. (NASDAQ: BNGO), and Genoox, the healthcare technology company on a mission to make it easier for doctors, clinicians and researchers to run clinical genetic applications and act on genetic sequencing results, announced today the launch of the Genoox Integrated Platform for identification of structural variants.

The Cystic Fibrosis Foundation announced today that it will commit at least $100 million over the next five years as part of a sweeping effort to address the chronic and intractable infections that are a hallmark of cystic fibrosis (CF).

As the global population keeps rising, the demand for food increases. To meet this ever growing demand, scientists are searching for new, efficient and innovative ways to properly feed people around the world.